Related Experiment Videos
Cutaneous epithelioid angiosarcoma
A J Marrogi1, S J Hunt, D J Cruz
1Department of Pathology, St. John's Mercy Medical Center, St. Louis, Missouri 63141.
The American Journal of Dermatopathology
|August 1, 1990
Summary
This study highlights that cutaneous epithelioid angiosarcoma, despite diagnostic challenges, may have a favorable prognosis. Early recognition of this rare cancer is crucial for patient outcomes.
Area of Science:
- Oncology
- Dermatopathology
- Surgical Pathology
Background:
- Cutaneous epithelioid angiosarcoma (EAS) is a rare vascular neoplasm.
- Solid pattern EAS presents diagnostic challenges due to resemblance to carcinomas.
- Immunohistochemistry and electron microscopy are key diagnostic tools.
Purpose of the Study:
- To investigate the clinicopathological features of cutaneous epithelioid angiosarcoma with a solid pattern.
- To evaluate the diagnostic difficulties and prognostic implications of this rare tumor.
- To assess the utility of immunohistochemistry and electron microscopy in diagnosing EAS.
Main Methods:
- Case study of three patients with cutaneous epithelioid angiosarcoma.
- Utilized immunohistochemistry and electron microscopy for detailed analysis.
- Clinical follow-up of patients for at least 48 months.
Main Results:
- Neoplasms exhibited a slow, protracted course with local recurrences and lymph node metastases.
- Histological diagnosis was delayed due to simulation of carcinomas and misleading ultrastructural findings.
- Two patients survived beyond 48 months, suggesting a potentially better prognosis.
Conclusions:
- Cutaneous epithelioid angiosarcoma with solid pattern can mimic other malignancies.
- Diagnostic delays can occur due to overlapping histological and ultrastructural features.
- Some cases of epithelioid angiosarcoma may have a more favorable prognosis than initially presumed.